264 articles in this topic
Discover how a hidden arm of your immune system called the complement system quietly drives the chronic inflammation linked to aging โ and what you can do about it.
A Phase 2 trial testing rituximab, infliximab, and tocilizumab for hard-to-treat non-ANCA vasculitis was terminated before completion.
A multi-biomarker study finds pwMS show accelerated thymic involution, senescent T cell expansion, and neuroinflammation linked to aging.
A comparative protein interaction map of SARS-CoV-2 and its bat progenitor uncovers the molecular switch behind immune evasion and species barriers.
A newly identified immune axis involving CD16+ ฮณฮด T cells and antibody-dependent killing may reshape how we understand HBV immune control.
A cluster randomized trial tests whether couples counseling plus stigma workshops can boost PrEP/ART uptake among young South African adults.
A landmark 48-RCT Cochrane review finds high-certainty evidence that convalescent plasma does not reduce death in moderate-to-severe COVID-19.
A runaway immune response โ not the pathogen itself โ drives citrus greening disease, echoing autoimmune mechanisms seen in human illness.
A completed Phase 3 trial tests placental MSC secretome injections against placebo in 60 GvHD patients at an Iranian hospital.
A new review reveals how cellular crosstalk, non-coding RNAs, and lung microbiota drive pulmonary fibrosis โ and where treatments may break through.
Scientists mapped key attack sites on measles virus proteins, finding human antibodies that powerfully neutralize MeV before and after exposure.
A novel biologic targeting IL-33 shows promising advances in COPD treatment, potentially reshaping how chronic lung disease is managed.
